JPMORGAN CHASE & CO - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$799,264
+186.7%
816,000
+197.8%
0.00%
Q2 2023$278,811
+1.8%
274,0000.0%0.00%
Q1 2023$274,000
+1053746.2%
274,000
+1041.7%
0.00%
Q4 2022$26
-100.0%
24,000
-92.4%
0.00%
Q2 2022$342,000
+936.4%
314,000
+982.8%
0.00%
Q4 2021$33,000
-92.0%
29,000
-91.6%
0.00%
Q2 2021$415,000
+783.0%
347,000
+654.3%
0.00%
Q3 2020$47,00046,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Wellesley Asset Management 69,285,732$54,302,4942.70%
CAMDEN ASSET MANAGEMENT L P /CA 50,071,000$48,664,0051.81%
Boussard & Gavaudan Investment Management LLP 6,577$6,483,0910.76%
READYSTATE ASSET MANAGEMENT LP 12,000,000$11,722,8000.59%
BRAIDWELL LP 15,500,000$15,141,9500.48%
WOLVERINE ASSET MANAGEMENT LLC 39,174,000$38,348,7170.43%
CSS LLC/IL 5,500,000$5,379,2800.35%
SHENKMAN CAPITAL MANAGEMENT INC 3,239,000$3,239,8250.24%
CAPSTONE INVESTMENT ADVISORS, LLC 15,174,000$14,823,4810.07%
Calamos Advisors LLC 9,500,000$9,281,5000.05%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders